HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $408,395 | -6.5% | 4,559 | -11.2% | 0.31% | -47.5% |
| Q2 2023 | $436,938 | +84.2% | 5,132 | +79.0% | 0.58% | +88.1% |
| Q1 2023 | $237,244 | -4.8% | 2,867 | -9.5% | 0.31% | -6.6% |
| Q4 2022 | $249,242 | +5.6% | 3,169 | -0.4% | 0.33% | -5.9% |
| Q3 2022 | $236,000 | -30.2% | 3,183 | -38.7% | 0.35% | +19.3% |
| Q2 2022 | $338,000 | -37.3% | 5,191 | -39.1% | 0.30% | -36.9% |
| Q1 2022 | $539,000 | -33.6% | 8,519 | -44.4% | 0.47% | -32.9% |
| Q4 2021 | $812,000 | -6.7% | 15,309 | +24.2% | 0.70% | -13.2% |
| Q3 2021 | $870,000 | -4.6% | 12,327 | -10.0% | 0.80% | -3.8% |
| Q2 2021 | $912,000 | +1069.2% | 13,691 | +512.6% | 0.84% | -21.6% |
| Q3 2014 | $78,000 | -13.3% | 2,235 | -11.8% | 1.07% | +6.9% |
| Q2 2014 | $90,000 | – | 2,535 | – | 1.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |